Komori
Nihon Trim (6788) · InitiativeRestated

Entry into the Operation of Hospitals for Chronic Disease Treatment in China

First written in FY2016. 16 of 24 entries say "Advanced", first in FY2017-Q1. Latest entry: FY2023.

24entries
8years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2018 – FY2020-Q2AdvancedFY2021-Q2 – FY2022-Q12016: 320162017: 420172018: 420182019: 320192020: 320202021: 320212022: 220222023: 22023
Same theme, other companies
Expansion into Medical Facility Construction and Operation ServicesA theme 4 companies write about · 0 as a headwind · 4 as a tailwind

1 other company's latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2023RestatedAnnual report

    「The hospital operation business in China is being developed around the concept of providing advanced Japanese-style medical services in chronic disease fields such as diabetes treatment and hemodialysis. Although progress has been slower than expected due to the impact of the COVID-19 pandemic and other factors, both the number of visitors and the utilization rate are steadily increasing.」

    Regarding the hospital business in China, the recognition that the number of visitors and the utilization rate are increasing has been reaffirmed, despite acknowledging delays in progress.
  2. FY2023-Q3AdvancedAnnual report

    「In the hospital business in China, approximately 300 outpatients are treated per day, and the 100 inpatient beds and 50 hemodialysis beds are operating at full capacity. An application is currently pending to add inpatient beds.」

    In the Chinese hospital business, approximately 300 outpatients per day are being treated, while 100 inpatient beds and 50 hemodialysis beds are operating at full capacity, and the process has advanced to applying to add inpatient beds.
  3. FY2023-Q1AdvancedAnnual report

    「In the hospital business in China, both the number of visitors and the utilization rate continue to increase, and we are aiming to achieve monthly profitability during fiscal 2022.」

    The number of visitors and the utilization rate were said to continue increasing, with monthly profitability targeted during fiscal 2022.
  4. FY2022-Q3RestatedAnnual report

    「In the hospital business in China, the number of visiting patients has steadily increased since treatment covered by public insurance began in February 2021, and we will continue working with our partners to expand the business toward achieving monthly profitability.」

    The increase in the number of patients following the start of treatment covered by public insurance and business expansion through cooperation with partners have been reaffirmed.
  5. FY2022-Q1AdvancedAnnual report

    「In the hospital business in China, the number of visiting patients has gradually increased since the start of treatment covered by public insurance in February this year, and the company is aiming to achieve monthly profitability within the current fiscal year. The number of diabetes patients in China is said to reach 320 million by 2025 (estimate by the International Diabetes Federation), and the number of hemodialysis patients is also rising rapidly.」

    The number of visiting patients has gradually increased since the start of treatment covered by public insurance, and a new target of achieving monthly profitability within the current fiscal year was announced.
  6. FY2021AdvancedAnnual report

    「Although the increase in the number of patients is slower than expected, partly due to the impact of the COVID-19 pandemic, treatment covered by public insurance began in February this year, and the number of patients has been increasing.」

    It was stated that Beijing Hanken Hospital began providing treatment covered by public insurance in February and that the number of patients is increasing.
  7. FY2021-Q3AdvancedAnnual report

    「In the hospital business in China, approval for coverage under public insurance was obtained in November, and preparations are currently under way to begin operations. Going forward, we aim to strengthen the operating structure, increase patient acquisition and expand the model throughout China.」

    The Chinese hospital business obtained approval for coverage under public insurance and advanced to the stage of preparing to begin operations and aiming to expand the model throughout China.
  8. FY2021-Q2AdvancedAnnual report

    「In the hospital business in China, the launch has been delayed, partly due to the impact of the COVID-19 pandemic, including the introduction of public insurance coverage. However, as restrictions on social activities have eased and consumption has recovered, the number of patients is gradually increasing, and we believe the business continues to have significant potential.」

    While acknowledging the delayed launch, it was stated that the number of patients is gradually increasing as social activity and consumption recover.
  9. FY2021-Q1RestatedAnnual report

    「In the hospital business in China, although affected by the COVID-19 pandemic, we will continue to make steady progress.」

    The policy of continuing the hospital business in China was reaffirmed while acknowledging the impact of the COVID-19 pandemic.
  10. FY2020SoftenedAnnual report

    「At present, partly due to the impact of the COVID-19 pandemic, the increase in the number of patients is slower than expected, but the number of patients is certain to increase once coverage under public insurance begins. Going forward, we will assess the operating status of Hanken Hospital in Beijing and aim to expand the business in China, using the hospital as our flagship.」

    For the hospital business in China, it was stated that the increase in the number of patients is slower than expected, with the business now described as aiming to expand after assessing the increase in patients following the introduction of public insurance coverage and the operating status of the Beijing hospital.
  11. FY2020-Q2AdvancedAnnual report

    「In the hospital operation business in China, we obtained approval to apply for coverage under public insurance earlier than usual and have already completed the application. We are currently preparing to begin treatment covered by public insurance, expand web-based promotion, and broaden the scope of the health management services agreement with our partner, state-owned insurer 中国人民保险集団股份有限公司 (PICC).」

    Approval to apply for coverage under public insurance was obtained and the application was completed. Preparations are also progressing toward the start of treatment covered by public insurance, web-based promotion and expansion of the health management services agreement with PICC.
  12. FY2020-Q1AdvancedAnnual report

    「As stated above, we entered into a contracted health management services agreement with state-owned insurer PICC covering 500 people. We plan to first expand this to 5,000 PICC employees. As for treatment covered by public insurance, applications can generally be submitted two years after a hospital opens, but Hanken Hospital received approval to apply after only 1 year, and is scheduled to begin providing treatment covered by public insurance shortly.」

    A contracted health management services agreement covering 500 people was signed with PICC, with a plan to expand it to 5,000 people. Beijing Hanken Hospital obtained approval to apply for treatment covered by public insurance 1 year after opening and advanced to the stage of preparing to begin such treatment.
  13. FY2019-Q3AdvancedAnnual report

    「In the hospital operation business in China, Beijing Hanken Hospital, the flagship hospital, is scheduled to begin electrolyzed-water dialysis treatment in February this year, and preparations are steadily progressing toward full-scale operations.」

    For Beijing Hanken Hospital, the planned start of electrolyzed-water dialysis treatment in February this year was announced, indicating progress toward the concrete stage of full-scale operations.
  14. FY2019-Q2AdvancedAnnual report

    「In the hospital operation business in China, Beijing Hanken Hospital, the flagship hospital, began accepting outpatients in July this year and inpatients from October. Operations are steadily progressing toward full-scale operation while coordinating with medical institutions in Japan.」

    Beijing Hanken Hospital began accepting outpatients in July and inpatients in October, advancing to the operating stage toward full-scale operations.
  15. FY2019-Q1AdvancedAnnual report

    「In the hospital business in China, we began accepting outpatients in stages from 25 July and are working diligently toward full-scale operations.」

    Beijing Hanken Hospital advanced to the stage of beginning to accept outpatients in stages from 25 July, and efforts toward full-scale operations are under way.
  16. FY2018AdvancedAnnual report

    「For the new hospital operation business, an opening ceremony was held on 9 May in Beijing, China, for a flagship hospital for the treatment of chronic diseases.」

    The Beijing flagship hospital for chronic disease treatment advanced to the stage of holding its opening ceremony. Preparations for an early multi-site rollout starting with the Beijing opening have also begun.
  17. FY2018-Q3SoftenedAnnual report

    「In the hospital operation business in China, construction delays and other factors affected the first hospital in Beijing, but it is expected to open successfully in March this year. Selection of potential properties for future multi-site expansion is also already under way.」

    Due to construction delays, the opening of the first Beijing hospital was pushed back from the previous schedule of by year-end and an opening ceremony in January to an expected opening in March this year. Meanwhile, selection of potential properties for multi-site expansion is progressing.
  18. FY2018-Q2AdvancedAnnual report

    「In the hospital operation business for treating chronic diseases such as diabetes and hemodialysis in China, preparations are steadily progressing toward opening the flagship hospital in Beijing, with the hospital scheduled to open by the end of the year and an opening ceremony scheduled for January. Concrete steps have also already begun toward an early multi-site rollout, including negotiations with potential partners in several other areas.」

    For the Beijing flagship hospital, the timing of opening by the end of the year and holding an opening ceremony in January has been specified, and concrete steps toward a multi-site rollout have begun through negotiations with potential partners in several areas.
  19. FY2018-Q1RestatedAnnual report

    「In the hospital operation business for treating chronic diseases such as diabetes and blood-related dialysis in China, preparations are steadily progressing toward opening the flagship hospital in Beijing, with the aim of opening it around autumn this year.」

    The target of opening the Beijing flagship hospital around autumn and the continuation of preparations have been reaffirmed.
  20. FY2017AdvancedAnnual report

    「To open the flagship hospital in Beijing, its operating company, 漢琨國際控股有限公司, has steadily advanced preparations, including entering into an agreement in February this year with major domestic trading companies and others to raise an additional US$9.4 million for capital investment, and is aiming to open the hospital around autumn this year.」

    For the Beijing flagship hospital, an agreement was signed to raise US$9.4 million in capital investment funds, and preparations are progressing toward the target opening around autumn.
  21. FY2017-Q3AdvancedAnnual report

    「For the project to establish hospitals in the People's Republic of China for treating chronic diseases such as diabetes and patients requiring hemodialysis, preparations are progressing smoothly with the goal of opening the flagship hospital in Beijing in September this year. With support from the Cabinet Secretariat's Office for Healthcare Policy, the project plans to provide Japanese-style medical services in China, including electrolyzed-water dialysis and the use of our electrolyzed hydrogen water generators, aimed at preventing the progression of diabetes among the nearly 200 million diabetes patients in the country, through a multi-site rollout of hospitals.」

    For the Beijing flagship hospital, a target opening date of September this year has been specified, and plans for a multi-site rollout of Japanese-style medical services incorporating electrolyzed-water dialysis and water generators have also become more concrete.
  22. FY2017-Q2RestatedAnnual report

    「In China, where the number of diabetes patients is said to be approaching 200 million, we are planning, through public-private cooperation, a multi-site rollout of hospitals providing Japanese-style medical services aimed at preventing the progression of diabetes. Preparations are currently under way to open the first flagship hospital in Beijing.」

    Preparations continue for a multi-site rollout in China of hospitals providing Japanese-style medical services, as well as for the opening of a flagship hospital in Beijing.
  23. FY2017-Q1AdvancedAnnual report

    「Preparations to open a flagship hospital in Beijing are progressing smoothly for the hospital operation business in China.」

    Regarding entry into hospitals for chronic disease treatment in China, concrete progress is being made, with preparations for opening a flagship hospital in Beijing proceeding smoothly.
  24. FY2016First statedAnnual report

    「Centered on a team of medical professionals familiar with expanding Japanese-style diabetes care services in China, and in cooperation with major trading companies, healthcare-related companies and 一般社団法人Medical Excellence JAPAN (MEJ), while receiving support from the Cabinet Secretariat's Office for Healthcare Policy, we will provide Japanese-style medical services in the fields of diabetes treatment, dialysis treatment and other chronic diseases in China.」

    The plan is to expand into China through cooperation with medical professionals, major trading companies, healthcare companies, MEJ and government agencies.
Moved together

"Storage, research and provision to medical institutions of cord blood-derived stem cells" moved the same way as this thread, in the same document, in 15 of its 24 moves.

151514131211★123456
  1. ★This thread
  2. 1Storage, research and provision to medical institutions of cord blood-derived stem cells15×
  3. 2Expansion of cord blood bank storage capacity15×
  4. 3Full-scale rollout of the electrolysis water dialysis system14×
  5. 4Expansion of Overseas Sales Channels and Production Facilities, Centered on Indonesia13×
  6. 5Clarification of the functions of electrolyzed hydrogen water and differentiation from other types of water12×
  7. 6Clinical Evidence for Electrolyzed Water Hemodialysis and Raising Awareness11×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Nihon Trim yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Entry into the Operation of Hospitals for Chronic Disease Treatment in China | NIHON TRIM CO.,LTD. (6788) | Komori